ME insider filings
23andMe Holding Co. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-02-21. Screen ME transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ME between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — 23andMe Holding Co.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-02-21 | 4 | Selsavage Joseph Anthony — Chief Financial & Actng Ofcr | Tax withholding (F): 5,654 @ $2.74 | EDGAR |
| 2024-11-21 | 4 | Selsavage Joseph Anthony — Chief Financial & Actng Ofcr | Tax withholding (F): 5,279 @ $3.15 | EDGAR |
| 2024-08-28 | 4 | Mohan Neal — Director | Grant/award (A): 658,485 @ $0 | EDGAR |
| 2024-08-28 | 4 | Chung Patrick S — Director | Grant/award (A): 658,485 @ $0 · Grant/award (A): 202,035 @ $0.33 | EDGAR |
| 2024-08-28 | 4 | MONTGOMERY RICE VALERIE MD — Director | Grant/award (A): 658,485 @ $0 · Grant/award (A): 194,552 @ $0.33 | EDGAR |
| 2024-08-28 | 4 | Taylor Peter J. — Director | Grant/award (A): 658,485 @ $0 | EDGAR |
| 2024-08-28 | 4 | Hernandez Sandra R MD — Director | Grant/award (A): 658,485 @ $0 · Grant/award (A): 149,655 @ $0.33 | EDGAR |
| 2024-08-28 | 4 | BOTHA ROELOF — Director | Grant/award (A): 658,485 @ $0 · Grant/award (A): 179,586 @ $0.33 | EDGAR |
| 2024-08-28 | 4 | SCHELLER RICHARD H — Director | Grant/award (A): 658,485 @ $0 | EDGAR |
| 2024-08-21 | 4 | Selsavage Joseph Anthony — Chief Financial & Actng Ofcr | Tax withholding (F): 110,388 @ $0.36 | EDGAR |
| 2024-08-21 | 4 | Richards William G — Head of Therapeutics Discovery | Tax withholding (F): 57,365 @ $0.36 | EDGAR |
| 2024-07-02 | 4 | MONTGOMERY RICE VALERIE MD — Director | Grant/award (A): 15,337 @ $0 | EDGAR |
| 2024-07-02 | 4 | Taylor Peter J. — Director | Grant/award (A): 57,515 @ $0 | EDGAR |
| 2024-07-02 | 4 | Hernandez Sandra R MD — Director | Grant/award (A): 57,515 @ $0 | EDGAR |
| 2024-05-23 | 4 | Selsavage Joseph Anthony — Chief Financial & Actng Ofcr | Grant/award (A): 1,000,000 @ $0 | EDGAR |
| 2024-05-21 | 4 | Selsavage Joseph Anthony — Interim CFO | Tax withholding (F): 36,913 @ $0.55 | EDGAR |
| 2024-05-21 | 4 | Richards William G — Head of Therapeutics Discovery | Tax withholding (F): 16,106 @ $0.55 | EDGAR |
| 2024-05-21 | 4 | HIBBS KATHY L — Chief Administrative Officer | Tax withholding (F): 35,282 @ $0.55 | EDGAR |
| 2024-05-06 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,551 @ $0.42 · Sale (S): 38,551 @ $0.49 · Option exercise (M): 38,551 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.47 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.50 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-03-22 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.46 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.53 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.61 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Richards William G — Head of Therapeutics Discovery | Tax withholding (F): 18,497 @ $0.72 | EDGAR |
| 2024-02-21 | 4 | Selsavage Joseph Anthony — Interim CFO | Tax withholding (F): 42,395 @ $0.72 | EDGAR |
| 2024-02-21 | 4 | HIBBS KATHY L — Chief Administrative Officer | Tax withholding (F): 40,522 @ $0.72 | EDGAR |
| 2024-02-16 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.78 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.73 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.72 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2023-12-29 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.93 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2023-12-18 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.97 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2023-12-01 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.88 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2023-11-21 | 4 | Richards William G — Head of Therapeutics Discovery | Tax withholding (F): 5,695 @ $0.91 | EDGAR |
| 2023-11-21 | 4 | Selsavage Joseph Anthony — Interim CFO | Tax withholding (F): 6,208 @ $0.91 | EDGAR |
| 2023-11-21 | 4 | HIBBS KATHY L — Chief Administrative Officer | Tax withholding (F): 4,627 @ $0.91 | EDGAR |
| 2023-11-17 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.77 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2023-11-03 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.87 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2023-10-20 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.81 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2023-10-06 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $0.84 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2023-09-25 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 38,548 @ $0.42 · Sale (S): 38,548 @ $1.00 · Option exercise (M): 38,548 (derivative) @ $0 | EDGAR |
| 2023-09-19 | 4 | Wojcicki Anne — Chief Executive Officer, Director, 10% owner | Grant/award (A): 9,527,115 (derivative) @ $0 | EDGAR |
| 2023-09-19 | 4 | Selsavage Joseph Anthony — Interim CFO | Grant/award (A): 1,025,992 @ $0 · Grant/award (A): 496,204 (derivative) @ $0 | EDGAR |
| 2023-09-19 | 4 | Richards William G — Head of Therapeutics Discovery | Grant/award (A): 344,050 @ $0 · Grant/award (A): 115,641 @ $0 · Grant/award (A): 166,394 (derivative) @ $0 | EDGAR |
| 2023-09-19 | 4 | HIBBS KATHY L — Chief Administrative Officer | Grant/award (A): 1,025,992 @ $0 · Grant/award (A): 496,204 (derivative) @ $0 | EDGAR |
| 2023-09-11 | 4 | HIBBS KATHY L — Chief Administrative Officer | Option exercise (M): 40,894 @ $0.42 · Sale (S): 40,894 @ $1.06 · Option exercise (M): 40,896 (derivative) @ $0 | EDGAR |
| 2023-09-08 | 4 | Taylor Peter J. — Director | Grant/award (A): 137,566 @ $0 | EDGAR |
| 2023-09-08 | 4 | Hernandez Sandra R MD — Director | Grant/award (A): 148,492 @ $0 · Grant/award (A): 45,871 @ $1.09 | EDGAR |
| 2023-09-08 | 4 | BOTHA ROELOF — Director, 10% owner | Grant/award (A): 138,334 @ $0 · Grant/award (A): 55,045 @ $1.09 | EDGAR |
| 2023-09-08 | 4 | SCHELLER RICHARD H — Director | Grant/award (A): 165,088 @ $0 | EDGAR |
Recent 8-K events — 23andMe Holding Co.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-12-04 | 8-K | 1.03 — Bankruptcy or Receivership 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-22 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2025-08-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-08-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-15 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ME returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →